Your session is about to expire
← Back to Search
Automated Smoking Cessation Outreach for Cancer Patients
N/A
Recruiting
Led By Janice Tsoh, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 months
Awards & highlights
Study Summary
This trial will test if a program called CareConnect (AAC + IVR) helps cancer patients quit smoking.
Who is the study for?
This trial is for adult cancer patients who smoke or use tobacco, including e-cigarettes. Participants must understand English, Spanish, Cantonese, or Mandarin and be willing to sign a consent form. They should have visited a UCSF Cancer Center-affiliated department recently.Check my eligibility
What is being tested?
The study tests 'CareConnect', which combines advice on quitting smoking with automated phone messages tailored for cancer patients. It aims to see if this helps more people quit smoking compared to usual care methods.See study design
What are the potential side effects?
Since the interventions involve counseling and educational messages rather than medications, there are no direct physical side effects expected from participating in this trial.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Proportion of participants who report using any smoking cessation resources
Secondary outcome measures
Mean Satisfaction Ratings (CareConnect Group Only)
Proportion of participants who started the call and chose the referrals
Trial Design
2Treatment groups
Experimental Treatment
Group I: CareConnect (Intervention)Experimental Treatment2 Interventions
Participants will receive automated 'CareConnect' calls/SMS text at enrollment. The call protocol will include up to 2 calls on 2 consecutive days if no response to the first call. If there is no response to call, a follow up SMS 3-4 days later. Each CareConnect contact will include (1) assessment, (2) motivational enhancement tailored to participants' tobacco use status and importance of quitting; and (3) multiple referral options (UCSF Fontana Tobacco Treatment Center (FTTC)/tobacco treatment specialist, Quitline, or smokefreeTXT from smokefree.gov), offered after the motivational enhancement message. CareConnect will notify the UCSF tobacco treatment specialist of participants acceptance of any of the referral options. Referral options will be documented by the specialist on the participants electronic health record (EHR). All participants who have completed the CareConnect call will be contacted by research staff for a 3-month survey to be completed online or by telephone.
Group II: AutoReach (Control)Experimental Treatment2 Interventions
Participants will receive automated AutoReach calls/Short Message Service (SMS) text at enrollment provides one referral option (speaking with a tobacco treatment specialist) and an option for sending information on cessation resources. All participants who have completed the AutoReach call will be contacted by research staff for a 3-month survey to be completed online or by telephone.
Find a Location
Who is running the clinical trial?
University of California, San FranciscoLead Sponsor
2,507 Previous Clinical Trials
15,238,175 Total Patients Enrolled
Tobacco Related Disease Research ProgramOTHER
25 Previous Clinical Trials
20,218 Total Patients Enrolled
Janice Tsoh, PhDPrincipal InvestigatorUniversity of California, San Francisco
7 Previous Clinical Trials
2,868 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 18 years old or older.I understand and can follow the study's procedures.I speak English, Spanish, Cantonese, or Mandarin.I have been diagnosed with cancer.I have seen a UCSF-affiliated cancer doctor in the last 3 months.
Research Study Groups:
This trial has the following groups:- Group 1: CareConnect (Intervention)
- Group 2: AutoReach (Control)
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this study currently recruiting participants?
"Based on the data hosted by clinicaltrials.gov, this medical trial has concluded its recruitment phase. The study was initially posted on September 1st 2023 and last updated April 13th 2023. However, there are 653 other trials actively enrolling patients currently available to join."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger